Aesthetic Medical Hldngs Group EBITDA 2019-2024 | PAIYY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Aesthetic Medical Hldngs Group ebitda from 2019 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Aesthetic Medical Hldngs Group ebitda from 2019 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$160.9B
Elevance Health (ELV)	$91.8B
Cencora (COR)	$49.1B
Natera (NTRA)	$23.4B
DiDi Global (DIDIY)	$22.6B
ICON (ICLR)	$16.4B
Revvity (RVTY)	$15.4B
Avantor (AVTR)	$15.2B
BioMerieux (BMXMF)	$14.4B
Viatris (VTRS)	$13.5B
CochLear (CHEOY)	$13B
Solventum (SOLV)	$12.8B
Doximity (DOCS)	$11B
Medpace Holdings (MEDP)	$10.9B
EUROFINS SCIENT (ERFSF)	$10.4B
HealthEquity (HQY)	$9.6B
Charles River Laboratories (CRL)	$8.4B
Sonic Healthcare (SKHHY)	$8.3B
Amplifon S.p.A (AMFPF)	$6.1B
Bausch + Lomb (BLCO)	$6.1B
BrightSpring Health Services (BTSG)	$4.1B
Organon (OGN)	$4B
Sotera Health (SHC)	$3.9B
Surgery Partners (SGRY)	$3.2B
Concentras Parent (CON)	$3B
Alignment Healthcare (ALHC)	$3B
PACS (PACS)	$2.2B
Premier (PINC)	$2.2B
Ardent Health Partners (ARDT)	$2.1B
GeneDx Holdings (WGS)	$2.1B